BioMedicine (Taiwan)
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 3.0 | Q1 | 78.6% | 0.585 | Q2 | 66.7% |
| 2024 | 2.5 | Q1 | 78.1% | 0.668 | Q2 | 72.0% |
| 2023 | 2.1 | Q2 | 74.7% | 0.513 | Q2 | 65.8% |
| 2022 | 1.7 | 64.7% | 0.320 | Q3 | 52.7% | |
| 2021 | — | 52.3% | 0.267 | Q3 | 47.9% | |
| 2020 | — | — | 0.498 | Q2 | 66.1% | |
| 2019 | — | — | 0.537 | Q2 | 69.5% | |
| 2018 | — | — | 1.022 | Q1 | 84.6% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
2211-8039
ISSN
2211-8020
country
coverage
2011-2025
